BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 3783903)

  • 1. Red blood cell porphobilinogen deaminase in the evaluation of acute intermittent porphyria.
    Pierach CA; Weimer MK; Cardinal RA; Bossenmaier IC; Bloomer JR
    JAMA; 1987 Jan; 257(1):60-1. PubMed ID: 3783903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological determination of porphobilinogen deaminase as a diagnostic measure in acute intermittent porphyria.
    Lannfelt L
    J Clin Chem Clin Biochem; 1990 May; 28(5):273-8. PubMed ID: 2380662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the diagnostic usefulness of determining porphobilinogen deaminase activity in the erythrocytes in patients with acute intermittent porphyria and in carriers of the gene of this type of porphyria].
    Gregor A; Kocyłowski M; Kostrzewska E
    Przegl Lek; 1986; 43(11):703-5. PubMed ID: 3575772
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased activity of porphobilinogen deaminase in erythrocytes during attacks of acute intermittent porphyria.
    Kostrzewska E; Gregor A
    Ann Clin Res; 1986; 18(4):195-8. PubMed ID: 3789651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute intermittent porphyria. Detection of asymptomatic carriers of the genetic defect].
    Grandchamp B; Grelier M; Nordmann Y
    Nouv Presse Med; 1975 Jun; 4(24):1801-2. PubMed ID: 1161481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uroporphyrinogen-I-synthetase in erythrocytes in acute intermittent porphyria].
    Iwanov ED; Adjarov D; Tsanev R
    Acta Biol Med Ger; 1977; 36(5-6):801-4. PubMed ID: 602585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence risk estimation of acute intermittent porphyria based on analysis of porphobilinogen deaminase activity: a Bayesian approach.
    Bonaïti-Pellié C; Phung L; Nordmann Y
    Am J Med Genet; 1984 Dec; 19(4):755-62. PubMed ID: 6517099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The measurement of erythrocyte uroporphyrinogen 1 synthase in the diagnosis of latent and acute intermittent porphyria.
    Brocklehurst D; Wider de Xifra EA; Batlle A
    Int J Biochem; 1980; 12(5-6):791-3. PubMed ID: 7450134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute intermittent porphyria. Familial study: detection of latent cases by the determination of erythrocyte uroporphyrinogen-1-synthetase activity].
    Guijarro Merino R; Villar Ortiz J; Lapetra Peralta J; Melero Bellido M; García Donas MA; Carneado de la Fuente J
    Med Clin (Barc); 1986 Mar; 86(8):323-7. PubMed ID: 3713356
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrocyte uroporphyrinogen I synthase activity as an indicator of acute porphyria.
    Forman DT
    Ann Clin Lab Sci; 1989; 19(2):128-32. PubMed ID: 2751241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria.
    Mustajoki P
    Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with the red cell uroporphyrinogen synthase (URO-S) assay in kindreds with acute intermittent porphyria (AIP).
    Kreimer-Birnbaum M; Bonkowsky HL; Bottomley SS
    Int J Biochem; 1980; 12(5-6):807-10. PubMed ID: 7450137
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of intermittent acute porphyria using urosynthetase assay. Results of 2 years].
    Grelier M; Grandchamp B; Phung N; de Verneuil H; Noire J; Nordmann Y; Husquinet H; Dodinval P
    Nouv Presse Med; 1977 Mar; 6(12):1045-7. PubMed ID: 850618
    [No Abstract]   [Full Text] [Related]  

  • 14. [Uroporphyrinogen synthase in erythrocytes in acute intermittent porphyria: new pathobiochemical aspects (author's transl)].
    Doss M; von Tiepermann R
    J Clin Chem Clin Biochem; 1978 Feb; 16(2):111-8. PubMed ID: 624910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.
    Herrick AL; McColl KE; Moore MR; Brodie MJ; Adamson AR; Goldberg A
    Br J Clin Pharmacol; 1989 Apr; 27(4):491-7. PubMed ID: 2497768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetase.
    Lamon JM; Frykholm BC; Tschudy DP
    J Med Genet; 1979 Apr; 16(2):134-9. PubMed ID: 458830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family studies on the activity of uroporphyrinogen I synthase in diagnosis of acute intermittent porphyria.
    Astrup EG
    Clin Sci Mol Med; 1978 Mar; 54(3):251-6. PubMed ID: 630801
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute intermittent porphyria in The Netherlands. Heterogeneity of the enzyme porphobilinogen deaminase.
    Wilson JH; De Rooy FW; Te Velde K
    Neth J Med; 1986; 29(11):393-9. PubMed ID: 3808142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute intermittent porphyria: uroporphyrinogen-I-synthetase activity in erythrocytes as a diagnostic index].
    Formgren B; Wetterberg L
    Lakartidningen; 1978 May; 75(19):1921-4. PubMed ID: 651454
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for latent acute intermittent porphyria: the value of measuring both leucocyte delta-aminolaevulinic acid synthase and erythrocyte uroporphyrinogen-1-synthase activities.
    McColl KE; Moore MR; Thompson GG; Goldberg A
    J Med Genet; 1982 Aug; 19(4):271-6. PubMed ID: 7120315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.